Suppr超能文献

脉冲照射下补充氧气和地形引导上皮下角膜交联术治疗进行性圆锥角膜。

Oxygen-supplemented and topography-guided epithelium-on corneal crosslinking with pulsed irradiation for progressive keratoconus.

机构信息

From the Queensland Eye Institute, Brisbane, Queensland, Australia (Cronin, Gunn); Medical Affairs, Burlington, Massachusetts (Chang); Cornea Service, Wills Eye Hospital, Philadelphia, Pennsylvania (Chang).

出版信息

J Cataract Refract Surg. 2024 Mar 1;50(3):209-216. doi: 10.1097/j.jcrs.0000000000001339.

Abstract

PURPOSE

To investigate the effects of customized topography-guided epithelium-on crosslinking (epi-on CXL) with oxygen supplementation on procedural efficacy and corrected distance visual acuity (CDVA) in patients with progressive keratoconus (KC) at 1 year.

SETTING

Private eye clinic, Brisbane, Australia.

DESIGN

Retrospective, single-center, nonrandomized case series.

METHODS

Topography-guided epi-on CXL using the Mosaic system was performed on patients with progressive KC. Oxygen goggles; transepithelial riboflavin; and pulsed, high UV-A irradiance (1 second on, 1 second off; 30 mW/cm2) were applied to enhance oxygen kinetics and bioavailabilities of riboflavin and UV-A. Guided by baseline topography, a higher UV-A dose (15 J/cm2) was applied to the area of steepest anterior curvature with decreasing fluence (as low as 7.2 J/cm2) toward the outer 9 mm. Postoperative CDVA and maximum keratometry (Kmax) were evaluated.

RESULTS

102 eyes (80 patients) were followed for 11.5 ± 4.8 months. At the latest follow-up, mean CDVA (logMAR), mean K, and Kmax (diopters [D]) improved from 0.18 ± 0.28, 46.2 ± 3.8, and 53.0 ± 5.67 at baseline to 0.07 ± 0.18, 45.8 ± 3.7, and 51.9 ± 5.56, respectively (P < .001). 3 eyes (3%) lost more than 1 CDVA line, and another 3 eyes (3%) had increased Kmax greater than 2 D. 43 eyes were followed for at least 12 months (n = 43): mean CDVA, mean K, and Kmax improved from 0.19 ± 0.33 logMAR, 46.5 ± 3.5 D, and 53.6 ± 5.67 D to 0.07 ± 0.17 logMAR, 46.0 ± 3.5 D, and 52.33 ± 5.49 D, respectively (P ≤ .002). No complications were observed.

CONCLUSIONS

Tailoring oxygen-supplemented epi-on CXL with differential UV-A energy distributions, guided by baseline topography, in patients with KC seems to be safe and effective. At 1 year, study reports sustained improved CDVA and corneal stabilization.

摘要

目的

研究在渐进性圆锥角膜(KC)患者中,使用定制的基于地形图的上皮交联(epi-on CXL)联合氧补充治疗在 1 年时对手术疗效和矫正距离视力(CDVA)的影响。

地点

澳大利亚布里斯班的私人眼科诊所。

设计

回顾性、单中心、非随机病例系列。

方法

使用 Mosaic 系统对进展性 KC 患者进行基于地形图的 epi-on CXL。使用氧护目镜;跨上皮核黄素;以及脉冲、高紫外-A 辐照度(1 秒开,1 秒关;30 mW/cm2),以增强氧动力学和核黄素及紫外-A 的生物利用度。根据基线地形图,在最陡的前曲率区域应用较高的紫外-A 剂量(15 J/cm2),并向外侧 9 毫米处逐渐降低光量(低至 7.2 J/cm2)。评估术后 CDVA 和最大角膜曲率(Kmax)。

结果

102 只眼(80 例患者)随访 11.5±4.8 个月。在最近的随访中,平均 CDVA(logMAR)、平均 K 值和 Kmax(屈光度 [D])从基线时的 0.18±0.28、46.2±3.8 和 53.0±5.67 分别改善至 0.07±0.18、45.8±3.7 和 51.9±5.56(P<0.001)。3 只眼(3%)视力丧失超过 1 行,另外 3 只眼(3%)Kmax 增加超过 2 D。43 只眼至少随访 12 个月(n=43):平均 CDVA、平均 K 值和 Kmax 分别从 0.19±0.33 logMAR、46.5±3.5 D 和 53.6±5.67 D 改善至 0.07±0.17 logMAR、46.0±3.5 D 和 52.33±5.49 D(P≤0.002)。未观察到并发症。

结论

在 KC 患者中,基于地形图的 epi-on CXL 联合氧补充治疗,根据基线地形图调整不同的紫外-A 能量分布,似乎是安全有效的。1 年后,研究报告显示 CDVA 持续改善和角膜稳定。

相似文献

1
Oxygen-supplemented and topography-guided epithelium-on corneal crosslinking with pulsed irradiation for progressive keratoconus.
J Cataract Refract Surg. 2024 Mar 1;50(3):209-216. doi: 10.1097/j.jcrs.0000000000001339.
2
Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis.
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):589-601. doi: 10.1007/s00417-024-06622-7. Epub 2024 Aug 31.
3
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis.
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1683-1692. doi: 10.1007/s00417-023-06287-8. Epub 2023 Nov 8.
4
Corneal collagen cross-linking for treating keratoconus.
Cochrane Database Syst Rev. 2015 Mar 24;2015(3):CD010621. doi: 10.1002/14651858.CD010621.pub2.
5
Standard and accelerated crosslinking protocols in keratoconus - differences and evolution at one year.
Rom J Ophthalmol. 2025 Apr-Jun;69(2):175-183. doi: 10.22336/rjo.2025.29.
6
Conventional Epithelial-Off Corneal Crosslinking in Patients With Progressive Keratoconus: 10-Year Outcomes.
Cornea. 2024 Jul 1;43(7):874-882. doi: 10.1097/ICO.0000000000003532. Epub 2024 Mar 27.
7
10
Customized Corneal Allogeneic Intrastromal Ring Segments (CAIRS) With Corneal Cross-linking for Post-LASIK Ectasia.
J Refract Surg. 2025 Jul;41(7):e709-e714. doi: 10.3928/1081597X-20250515-04. Epub 2025 Jul 1.

本文引用的文献

1
Corneal Cross-Linking: Epi-On.
Cornea. 2022 Oct 1;41(10):1203-1204. doi: 10.1097/ICO.0000000000003075. Epub 2022 Jul 4.
2
3
Keratoconus: An updated review.
Cont Lens Anterior Eye. 2022 Jun;45(3):101559. doi: 10.1016/j.clae.2021.101559. Epub 2022 Jan 4.
4
Risk Factors for Progression of Keratoconus and Failure Rate After Corneal Cross-linking.
J Refract Surg. 2021 Dec;37(12):816-823. doi: 10.3928/1081597X-20210830-01. Epub 2021 Dec 1.
5
6
Epithelium-on Corneal Collagen Cross-Linking with Hypotonic Riboflavin Solution in Progressive Keratoconus.
Clin Ophthalmol. 2021 Jul 7;15:2921-2932. doi: 10.2147/OPTH.S318317. eCollection 2021.
7
Risk factors for keratoconus progression after treatment by accelerated cross-linking (A-CXL): A prospective 24-month study.
J Fr Ophtalmol. 2021 Jun;44(6):863-872. doi: 10.1016/j.jfo.2020.08.040. Epub 2021 May 28.
8
Transepithelial Corneal Cross-linking With Supplemental Oxygen in Keratoconus: 1-Year Clinical Results.
J Refract Surg. 2021 Jan 1;37(1):42-48. doi: 10.3928/1081597X-20201111-01.
9
ABCD: A new classification for keratoconus.
Indian J Ophthalmol. 2020 Dec;68(12):2831-2834. doi: 10.4103/ijo.IJO_2078_20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验